Max L. Birnstiel
Affiliations: | Molecular Biology | Universität Zürich, Zürich, ZH, Switzerland |
Website:
http://www.imls.uzh.ch/aboutus/hof/cvmb.htmlGoogle:
"Max L. Birnstiel"Bio:
(1933 - 2014)
http://www.nasonline.org/member-directory/deceased-members/47084.html
http://dx.doi.org/10.3929/ethz-a-000150890
DOI: 10.1073%2Fpnas.1423755112
Mean distance: 10.03 | S | N | B | C | P |
Parents
Sign in to add mentorAlbert Frey-Wyssling | grad student | 1960 | ETH Zürich | |
(Ueber das Redoxpotential lebender und absterbender Pflanzengewebe(Tabakverbräunung) ) | ||||
James Frederick Bonner | post-doc | 1960-1963 | Caltech |
Children
Sign in to add traineeAdrian Bird | grad student | Edinburgh (Neurotree) | |
Meinrad Busslinger | grad student | Universität Zürich (Neurotree) | |
Michael Grunstein | grad student | Edinburgh | |
Bernhard Luscher | grad student | Universität Zürich (Neurotree) | |
Mary Lou Pardue | post-doc | (FlyTree) | |
Walter Schaffner | post-doc | Universität Zürich (FlyTree) | |
Stuart Gordon Clarkson | post-doc | 1970-1972 | Edinburgh |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fritz JH, Brunner S, Birnstiel ML, et al. (2004) The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens Vaccine. 22: 3274-3284 |
Birnstiel ML. (2002) The dawn of gene isolation Gene. 300: 3-11 |
Spinelli G, Birnstiel ML. (2002) The modulator is a constitutive enhancer of a developmentally regulated sea urchin histone H2A gene Bioessays. 24: 850-857 |
Mattner F, Fleitmann JK, Lingnau K, et al. (2002) Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: Induction of potent and long-lasting T-cell responses against cancer antigens Cancer Research. 62: 1477-1480 |
Cotten M, Baker A, Birnstiel ML, et al. (2001) Preparation of adenovirus-polylysine-DNA complexes. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 12.3 |
Birnstiel ML. (1999) Moving from Zurich to Vienna: Up or down? Biological Chemistry. 380: 111-112 |
Schmidt W, Maass G, Buschle M, et al. (1997) Generation of effective cancer vaccines genetically engineered to secrete cytokines using adenovirus-enhanced transferrinfection (AVET). Gene. 190: 211-6 |
Stingl G, Bröcker EB, Mertelsmann R, et al. (1997) Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Journal of Molecular Medicine (Berlin, Germany). 75: 297-9 |
Schmidt W, Buschle M, Zauner W, et al. (1997) Cell-free tumor antigen peptide-based cancer vaccines Proceedings of the National Academy of Sciences of the United States of America. 94: 3262-3267 |
Buschle M, Schmidt W, Zauner W, et al. (1997) Transloading of tumor antigen-derived peptides into antigen-presenting cells Proceedings of the National Academy of Sciences of the United States of America. 94: 3256-3261 |